Details for Patent: 5,635,485
✉ Email this page to a colleague
Summary for Patent: 5,635,485
| Title: | Erythromycin compounds |
| Abstract: | An erythromycin compound of Formula I or its non-toxic acid addition salt having antibiotic activity. |
| Inventor(s): | Constantin Agouridas, Jean-Francois Chantot, Alexis Denis, Solange G. D'Ambrieres, Odile L. Martret |
| Assignee: | Aventis Pharma SA |
| Application Number: | US08/426,067 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 5,635,485
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,635,485
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| France | 94 05368 | May 03, 1994 |
International Family Members for US Patent 5,635,485
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0680967 | ⤷ Start Trial | CA 2002 00001 | Denmark | ⤷ Start Trial |
| European Patent Office | 0680967 | ⤷ Start Trial | PA2002001 | Lithuania | ⤷ Start Trial |
| European Patent Office | 0680967 | ⤷ Start Trial | PA2002001,C0680967 | Lithuania | ⤷ Start Trial |
| European Patent Office | 0680967 | ⤷ Start Trial | SPC030/2001 | Ireland | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
